Second- or third-line chemotherapy in NSCLC

被引：0
|
作者：
Sorensen, JB [1 ]
机构：
[1] Natl Univ Hosp, Dept Oncol, Copenhagen, Denmark
来源：
LUNG CANCER | 2004年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [1] Second or third-line chemotherapy in NSCLC
    Sorensen, JB
    [J]. PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 69 - 75
  • [2] The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy
    Svaton, Martin
    Fiala, Ondrej
    Pesek, Milos
    Bortlicek, Zbynek
    Minarik, Marek
    Benesova, Lucie
    Topolcan, Ondrej
    [J]. ANTICANCER RESEARCH, 2016, 36 (03) : 1077 - 1082
  • [3] FOLFIRI regimen as second- and third-line chemotherapy for metastatic biliary tract or pancreatic cancer.
    Loioia, Fernanda Navarro
    Guedes Camandaroba, Marcos Pedro
    Oliveira Fernandes, Viviane Teodoro
    Rodrigues Pereira, Augusto Akikubo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Second- and third-line treatment of metastatic breast cancer with gemcitabine
    Brodowicz, T
    Möslinger, R
    Herscovici, V
    Vaclavik, I
    Wiltschke, C
    Kubista, E
    Zielinski, C
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S44 - S44
  • [5] Predictors of second- and third-line chemotherapy receipt in stage IV colon cancer Medicare beneficiaries
    Reese, Emily S.
    Onukwugha, Ebere
    Hanna, Nader
    Seal, Brian S.
    Mullins, C. Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [6] Capecitabine as Second- and Third-line Chemotherapy in the Treatment of Platinum-refractory Epithelial Ovarian Cancer
    Veljanoska, S.
    Klisarovska, V.
    Arsovski, O.
    Basevska, N.
    Stojkovski, I.
    Simonova, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S537 - S537
  • [7] Second- and third-line treatment for pediatric patients failing ART
    Giaquinto, C.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 68 - 68
  • [8] Second- and third-line chemotherapy regimens in elderly Medicare stage IV colon cancer patients.
    Bikov, Kaloyan A.
    Mullins, C. Daniel
    Onukwugha, Ebere
    Seal, Brian S.
    Hanna, Nader
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Pemetrexed as a Component of First-, Second- and Third-line Chemotherapy in Treating Patients with Metastatic Lung Adenocarcinoma
    Huang, Xin-En
    Tian, Guang-Yu
    Cao, Jie
    Xu, Xia
    Lu, Yan-Yan
    Wu, Xue-Yan
    Liu, Jin
    Shi, Lin
    Xiang, Jin
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (11) : 6663 - 6667
  • [10] Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene
    Krawczyk, Pawel
    Kowalski, Dariusz M.
    Krawczyk, Kamila Wojas
    Szczyrek, Michal
    Mlak, Radoslaw
    Rolski, Andrzej
    Szudy, Aneta
    Kieszko, Robert
    Winiarczyk, Kinga
    Milanowski, Janusz
    Krzakowski, Maciej
    [J]. ONCOLOGY REPORTS, 2013, 30 (03) : 1463 - 1472
12345